Healthcare provider profile · identity verified

Bridget Brady

Nurse Practitioner · MEMPHIS, TN · NPI 1336285162

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	428	137
Atorvastatin Calcium	Atorvastatin Calcium	390	127
Rosuvastatin Calcium	Rosuvastatin Calcium	306	92
Gabapentin	Gabapentin	258	87
Alprazolam	Alprazolam	246	54
Losartan Potassium	Losartan Potassium	244	77
Levothyroxine Sodium	Levothyroxine Sodium	236	64
Metformin Hcl	Metformin Hcl	235	66
Zolpidem Tartrate	Zolpidem Tartrate	224	38
Omeprazole	Omeprazole	201	57
Simvastatin	Simvastatin	192	59
Metoprolol Succinate	Metoprolol Succinate	178	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	172	26
Hydrochlorothiazide	Hydrochlorothiazide	157	46
Furosemide	Furosemide	148	46
Glimepiride	Glimepiride	141	44
Potassium Chloride	Potassium Chloride	139	40
Albuterol Sulfate Hfa	Albuterol Sulfate	135	47
Carvedilol	Carvedilol	132	42
Ezetimibe	Ezetimibe	131	42
Pantoprazole Sodium	Pantoprazole Sodium	128	44
Tramadol Hcl	Tramadol Hcl	126	30
Ozempic	Semaglutide	125	24
Trazodone Hcl	Trazodone Hcl	120	35
Famotidine	Famotidine	118	47
Jardiance	Empagliflozin	116	21
Montelukast Sodium	Montelukast Sodium	116	35
Meloxicam	Meloxicam	98	30
Metoprolol Tartrate	Metoprolol Tartrate	94	27
Olmesartan Medoxomil	Olmesartan Medoxomil	94	27
Sertraline Hcl	Sertraline Hcl	94	27
Azithromycin	Azithromycin	90	69
Escitalopram Oxalate	Escitalopram Oxalate	90	28
Donepezil Hcl	Donepezil Hcl	88	31
Pravastatin Sodium	Pravastatin Sodium	77	23
Metformin Hcl Er	Metformin Hcl	74	24
Allopurinol	Allopurinol	72	27
Lisinopril	Lisinopril	71	20
Pregabalin	Pregabalin	71	18
Tamsulosin Hcl	Tamsulosin Hcl	71	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	67	19
Amoxicillin	Amoxicillin	61	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	17
Telmisartan	Telmisartan	61	15
Duloxetine Hcl	Duloxetine Hcl	60	21
Clonidine Hcl	Clonidine Hcl	57	22
Bupropion Xl	Bupropion Hcl	56	17
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	55	11
Clopidogrel	Clopidogrel Bisulfate	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	19
Januvia	Sitagliptin Phosphate	52	13
Methylprednisolone	Methylprednisolone	52	46
Venlafaxine Hcl Er	Venlafaxine Hcl	51	15
Hydralazine Hcl	Hydralazine Hcl	50	19
Mounjaro	Tirzepatide	50	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	49	41
Eliquis	Apixaban	46	suppressed
Farxiga	Dapagliflozin Propanediol	46	suppressed
Tizanidine Hcl	Tizanidine Hcl	46	27
Fluconazole	Fluconazole	45	27
Spironolactone	Spironolactone	44	13
Buspirone Hcl	Buspirone Hcl	43	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	13
Benazepril Hcl	Benazepril Hcl	42	14
Synthroid	Levothyroxine Sodium	42	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	42	11
Citalopram Hbr	Citalopram Hydrobromide	41	15
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	20
Valacyclovir	Valacyclovir Hcl	38	13
Fluticasone Propionate	Fluticasone Propionate	37	23
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	27
Meclizine Hcl	Meclizine Hcl	34	15
Ramipril	Ramipril	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Diazepam	Diazepam	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Prednisone	Prednisone	31	11
Alendronate Sodium	Alendronate Sodium	30	suppressed
Atenolol	Atenolol	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	26
Estradiol	Estradiol	29	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Lorazepam	Lorazepam	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Cephalexin	Cephalexin	23	21
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Dexamethasone	Dexamethasone	22	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Zaleplon	Zaleplon	21	suppressed
Byetta	Exenatide	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Temazepam	Temazepam	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Linzess	Linaclotide	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Invokana	Canagliflozin	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Praluent Pen	Alirocumab	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Torsemide	Torsemide	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Baclofen	Baclofen	11	suppressed
Clonidine	Clonidine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error